ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,993.90
      -1.53%
      US Tech 100
      16,795.60
      -1.55%
      Dow Jones
      37,773.21
      -1.79%
      Brent Oil
      86.685
      -0.61%
      Bitcoin
      63,391.45
      -1.38%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG
      6. Terex Corp. (TXG)

      7. Terex Corp. (TXG) News

      TXG

      Terex (TXG)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TXG
      DateTimeSourceHeadlineSymbolCompany
      12:52PMiHub NewswireFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      04/10/20244:05PMPR Newswire (US)10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:TXG10x Genomics Inc
      03/26/20249:00AMPR Newswire (US)10x Genomics Commercially Launches Visium HD Spatial Gene Expression AssayNASDAQ:TXG10x Genomics Inc
      03/21/20244:05PMPR Newswire (US)10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelNASDAQ:TXG10x Genomics Inc
      03/13/20244:05PMPR Newswire (US)10x Genomics Begins Commercial Shipments of Chromium GEM-X ProductsNASDAQ:TXG10x Genomics Inc
      03/06/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      03/04/20246:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      02/26/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      02/26/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      02/26/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      02/22/20247:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      02/22/20247:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      02/22/20246:59PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      02/20/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      02/20/20244:05PMPR Newswire (US)10x Genomics to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:TXG10x Genomics Inc
      02/15/20245:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TXG10x Genomics Inc
      02/15/20245:16PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TXG10x Genomics Inc
      02/15/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      02/15/20244:05PMPR Newswire (US)10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024NASDAQ:TXG10x Genomics Inc
      02/13/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      02/07/20244:05PMPR Newswire (US)10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X TechnologyNASDAQ:TXG10x Genomics Inc
      02/05/20244:05PMPR Newswire (US)10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General MeetingNASDAQ:TXG10x Genomics Inc
      01/24/20244:05PMPR Newswire (US)10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024NASDAQ:TXG10x Genomics Inc
      01/18/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      01/16/20246:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      01/16/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      01/08/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      01/08/20249:00AMPR Newswire (US)10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 ResultsNASDAQ:TXG10x Genomics Inc
      12/29/20234:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      12/29/20234:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
       Showing the most relevant articles for your search:NASDAQ:TXG